Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.
Köhne CH, Catane R, Klein B, Ducreux M, Thuss-Patience P, Niederle N, Gips M, Preusser P, Knuth A, Clemens M, Bugat R, Figer I, Shani A, Fages B, Di Betta D, Jacques C, Wilke HJ.
Köhne CH, et al. Among authors: preusser p.
Br J Cancer. 2003 Sep 15;89(6):997-1001. doi: 10.1038/sj.bjc.6601226.
Br J Cancer. 2003.
PMID: 12966415
Free PMC article.
Clinical Trial.